Publications by authors named "A Gozalan"
Background: West Nile virus (WNV)-related illness is a global health problem. Understanding the seropositivity rates and identifying the risk factors related to WNV in various animal species including humans is crucial for the implementation of effective prevention strategies.
Objectives: Assess the rate of seropositivity and the risk factors associated with WNV seropositivity.
Article Synopsis
- Respiratory tract infections are a significant health issue globally, leading to high rates of illness and death across all ages.
- This study analyzed 8825 respiratory specimens over three years to understand the impact of the COVID-19 pandemic on respiratory viruses and their co-infections through multiplex PCR testing.
- The findings revealed that 24.4% of samples contained at least one viral agent, with a majority being single infections, while a smaller percentage showed multiple viral agents, highlighting the complex interplay of respiratory pathogens during the pandemic.
Background: Non-pharmaceutical interventions (NPIs) applied to limit the SARS-CoV-2 pandemic also affect the circulation and seasonal characteristics of other respiratory viruses.
Objectives: Assess the impact of NPIs on the spread and seasonal characteristics of non-SARS-CoV-2 respiratory viruses and examine viral respiratory co-infections.
Design: Retrospective cohort SETTING: Single center in Turkey.
Numerous vaccines have been generated to decrease the morbidity and mortality of COVID-19. This study aims to evaluate the immunogenicity of the heterologous boosts by BioNTech against homologous boosts by CoronaVac at three-month intervals in two health care worker (HCW) cohorts, with or without prior COVID-19, for one year post-vaccination. This is a prospective cohort study in which the humoral responses of 386 HCWs were followed-up longitudinally in six main groups according to their previous COVID-19 exposure and vaccination status.
View Article and Find Full Text PDFComparison of clinical characteristics of wild-type SARS-CoV-2 and Omicron.
Rev Assoc Med Bras (1992)
December 2022
Objective: This study aimed to investigate the effect of mutations by comparing wild-type SARS-CoV-2 and Omicron regarding clinical features in patients with COVID-19. It also aimed to assess whether SARS-CoV-2 cycle threshold value could predict COVID-19 severity.
Methods: A total of 960 wild-type and 411 Omicron variant patients with positive results in SARS-CoV-2 real-time reverse transcriptase polymerase chain reaction test from oropharyngeal and/or nasopharyngeal samples during their hospital admissions were included in this retrospective study.